Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,463 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Atrial Fibrillation is Associated with Femoropopliteal Totally Occlusive In-Stent Restenosis: A Single-Center, Retrospective, Observational Study.
Honda Y, Hirano K, Yamawaki M, Araki M, Kobayashi N, Sakamoto Y, Mori S, Tsutsumi M, Makino K, Shirai S, Mizusawa M, Nakano T, Ito Y. Honda Y, et al. Among authors: araki m. J Interv Cardiol. 2021 Feb 3;2021:8852466. doi: 10.1155/2021/8852466. eCollection 2021. J Interv Cardiol. 2021. PMID: 33623483 Free PMC article.
Predictive factors of re-restenosis after repeated sirolimus-eluting stent implantation for SES restenosis and clinical outcomes after percutaneous coronary intervention for SES restenosis.
Chatani K, Muramatsu T, Tsukahara R, Ito Y, Ishimori H, Hirano K, Nakano M, Yamawaki M, Araki M, Sakurai M, Iuchi K, Nozawa T, Inoue H. Chatani K, et al. Among authors: araki m. J Interv Cardiol. 2009 Aug;22(4):354-61. doi: 10.1111/j.1540-8183.2009.00482.x. J Interv Cardiol. 2009. PMID: 19689659 Free article.
Natural history of side branches jailed by drug-eluting stents.
Yamawaki M, Muramatsu T, Araki M, Hirano K, Nakano M, Ishimori H, Ito Y, Murasato Y, Ueno T, Tsukahara R. Yamawaki M, et al. Among authors: araki m. J Interv Cardiol. 2012 Feb;25(1):37-46. doi: 10.1111/j.1540-8183.2011.00675.x. Epub 2011 Oct 10. J Interv Cardiol. 2012. PMID: 21981423 Free article.
Impact of ultra-long second-generation drug-eluting stent implantation.
Honda Y, Muramatsu T, Ito Y, Sakai T, Hirano K, Yamawaki M, Araki M, Kobayashi N, Takimura H, Sakamoto Y, Mouri S, Tsutumi M, Takama T, Takafuji H, Tokuda T, Makino K. Honda Y, et al. Among authors: araki m. Catheter Cardiovasc Interv. 2016 Feb 1;87(2):E44-53. doi: 10.1002/ccd.26010. Epub 2015 May 23. Catheter Cardiovasc Interv. 2016. PMID: 26010548
Comparison of first- and second-generation drug-eluting stent efficacies for treating left main and/or three-vessel disease: a propensity matched study.
Kobayashi N, Ito Y, Hirano K, Yamawaki M, Araki M, Sakai T, Takimura H, Sakamoto Y, Mori S, Tsutsumi M, Takama T, Takafuji H, Maruyama T, Honda Y, Tokuda T, Makino K, Shirai S, Muramatsu T. Kobayashi N, et al. Among authors: araki m. Heart Vessels. 2016 Dec;31(12):1930-1942. doi: 10.1007/s00380-016-0824-z. Epub 2016 Mar 2. Heart Vessels. 2016. PMID: 26936450
Frequency and predictors of bleeding events after 2nd generation drug-eluting stent implantation differ depending on time after implantation.
Honda Y, Yamawaki M, Mori S, Shirai S, Makino K, Tokuda T, Maruyama T, Takafuji H, Takama T, Tsutumi M, Sakamoto Y, Takimura H, Kobayashi N, Araki M, Hirano K, Sakai T, Ito Y. Honda Y, et al. Among authors: araki m. J Cardiol. 2017 Apr;69(4):632-639. doi: 10.1016/j.jjcc.2016.05.017. Epub 2016 Jun 29. J Cardiol. 2017. PMID: 27371500 Free article.
1,463 results